Contacts: James E. Fickenscher/CFOAuxilium Pharmaceuticals, Inc.(484) 321-5900 email@example.comWilliam Q. Sargent Jr./ VP IRAuxilium Pharmaceuticals, Inc.(484) 321-5900 firstname.lastname@example.org SOURCE Auxilium Pharmaceuticals, Inc.
Trade-Ideas LLC identified Auxilium Pharmaceuticals (AUXL) as a strong on high relative volume candidate
In 2014 drugmakers long on cash but short on growth bought quick access to markets that would have otherwise taken years to build. Can this continue?
Cantor Fitzgerald upgraded Endo International (ENDP) to 'hold' from 'sell' and set a price target of $56.
The S&P 500 suffered its worst day in six months as Wall Street endured a broad-based selloff on eurozone fears.